Researchers have made a significant first step with newly engineered biomaterials for cell transplantation that could help lead to a possible cure for Type 1 diabetes, which affects about 3 million Americans.
Georgia Tech engineers and Emory University clinicians have successfully engrafted insulin-producing cells into a diabetic mouse model, reversing diabetic symptoms in the animal in as little as 10 days.
The research team engineered a biomaterial to protect the cluster of insulin-producing cells – donor pancreatic islets – during injection. The material also contains proteins to foster blood vessel formation that allow the cells to successfully graft, survive and function within the body.
“It’s very promising,” said Andrés Garcia, Georgia Tech professor of mechanical engineering. “There is a lot of excitement because not only can we get the islets to survive and function, but we can also cure diabetes with fewer islets than are normally needed.”
The research article – a partnership with Emory’s Dr. Robert Taylor and Dr. Peter Thule that was funded in part by theJDRF, the leading global organization funding Type 1 diabetes research – will be published in the June issue of the journal Biomaterials.
Organizations such as JDRF are dedicated to finding a cure for Type 1 diabetes, a chronic disease that occurs when the pancreas produces little or no insulin, a hormone that allows the transport of sugar and other nutrients into tissues where they are converted to energy needed for daily life.
Pancreatic islet transplantation re-emerged as a promising therapy in the late 1990s. Patients with diabetes typically find it difficult to comply with multiple daily insulin injections, which only partially improve long-term outcomes. Successful islet transplantation would remove the need for patients to administer insulin. While islet transplantation trials have had some success, and control of glucose levels is often improved, diabetic symptoms have returned in most patients and they have had to revert to using some insulin.
Unsuccessful transplants can be attributed to several factors, researchers say. The current technique of injecting islets directly into the blood vessels in the liver causes approximately half of the cells to die due to exposure to blood clotting reactions. Also, the islets – metabolically active cells that require significant blood flow – have problems hooking up to blood vessels once in the body and die off over time.
Georgia Tech and Emory researchers engineered a hydrogel, a material compatible with biological tissues that is a promising therapeutic delivery vehicle. This water-swollen, cross-linked polymer surrounds the insulin-producing cells and protects them during injection. The hydrogel containing the islets was delivered to a new injection site on the outside of the small intestine, thus avoiding direct injection into the blood stream.
Once in the body, the hydrogel degrades in a controlled fashion to release a growth factor protein that promotes blood vessel formation and connection of the transplanted islets to these new vessels. In the study, the blood vessels effectively grew into the biomaterial and successfully connected to the insulin-producing cells.
Four weeks after the transplantation, diabetic mice treated with the hydrogel had normal glucose levels, and the delivered islets were alive and vascularized to the same extent as islets in a healthy mouse pancreas. The technique also required fewer islets than previous transplantation attempts, which may allow doctors to treat more patients with limited donor samples. Currently, donor cells from two to three cadavers are needed for one patient.
While the new biomaterial and injection technique is promising, the study used genetically identical mice and therefore did not address immune rejection issues common to human applications. The research team has funding from JDRF to study whether an immune barrier they created will allow the cells to be accepted in genetically different mice models. If successful, the trials could move to larger animals.
“We broke up our strategy into two steps,” said Garcia, a member of Georgia Tech’s Petit Institute for Bioengineering and Bioscience. “We have shown that when delivered in the material we engineered, the islets will survive and graft. Now we must address immune acceptance issues.”
The Latest Bing News on:
Diabetes mellitus type 1
- Amarna Therapeutics announces appointment of Aurelia Caparrós as new Chief Business Officeron April 19, 2024 at 1:08 am
Aurelia Caparros Aurelia Caparrós, appointed as new Chief Business Officer of Leiden, The Netherlands, 19 April 2024 – Amarna Therapeutics, a privately-held biotechnology company developing ...
- Chronic exercise tied to lower appetite in patients with type 2 diabetes: Studyon April 17, 2024 at 9:15 pm
Germany: A systematic review published in Nutrients has shed light on the impact of acute and chronic exercise on appetite and appetite regulation in patients with prediabetes or type 2 diabetes ...
- Launch of new international medical code for presymptomatic type 1 diabeteson April 17, 2024 at 3:30 am
University of Birmingham and NHS England researchers have created a diagnostic code for presymptomatic type 1 diabetes to enhance healthcare treatment.
- Type 1 Diabeteson April 15, 2024 at 5:00 pm
Type 1 diabetes mellitus describes a condition where the body cannot produce insulin which leads to a very high level of blood sugar and associated complications. The condition, which usually ...
- Bexagliflozin found as effective as dapagliflozin for glycemic control in diabetes: Studyon April 10, 2024 at 9:00 pm
China: A 24-week, phase 3 trial has shed light on the safety and efficacy of bexagliflozin versus dapagliflozin as an adjunct to metformin in Chinese patients with type 2 diabetes mellitus (T2D).
- Can A Low-fat Vegan Diet Reduce Insulin Requirement In Type 1 Diabetes?on April 9, 2024 at 9:45 am
Vegan diet contains fibre which can aid in managing blood sugar levels Read this article to know how vegan food can reduce insulin requirements ...
- Ask A Doctor: How Do You Develop Diabetes Type 1?on April 7, 2024 at 2:28 pm
Expert opinion from Sarath Chandr Rellu MBBS · 2 years of experience · India Diabetes type—1 is insulin-dependent diabetes mellitus, in which there is little or no insulin production from pancreas.
- Professional Faqs: How Do You Develop Diabetes Type 1?on April 6, 2024 at 2:28 pm
Expert opinion from Sarath Chandr Rellu MBBS · 2 years of experience · India Diabetes type—1 is insulin-dependent diabetes mellitus, in which there is little or no insulin production from pancreas.
- Diabetes Mellituson March 26, 2024 at 5:00 pm
Diabetes mellitus, often simply referred to as diabetes ... and type 2 diabetes may be controlled with medications. Both type 1 and 2 are chronic conditions that usually cannot be cured.
- Diabetes Mellitus Type 1 Newson August 9, 2022 at 5:00 pm
Increase in New-Onset Type 1 Diabetes in Kids During Pandemic The early days of the COVID-19 pandemic saw an increase in new-onset pediatric diabetes and DKA, while children with pre-existing ...
The Latest Google Headlines on:
Diabetes mellitus type 1
[google_news title=”” keyword=”Diabetes mellitus type 1″ num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Cure for type 1 diabetes
- American College Of Physicians Officially Recommends GLP-1s Like Ozempic For Diabetes Treatment—Despite Shortage Concernson April 19, 2024 at 10:10 am
The ACP recommends treating Type 2 diabetes using GLP-1 agonists to reduce the risk for all causes of ... may be a “significant barrier” in providing patients with access to treatment, according to an ...
- Finger Lakes Tour de Cure participants gear up for diabetes cycling fundraiseron April 19, 2024 at 3:48 am
The Finger Lakes Tour de Cure is still six weeks away, but riders have been pedaling forward to raise money for the American Diabetes Association.
- Siblings' Rare Genetic Mutation Offers Clues for Type 1 Diabetes Therapyon April 19, 2024 at 1:38 am
Two siblings who have the only known mutations in a key gene anywhere in the world have helped scientists gain new insights that could help progress the search for new treatments in type 1 diabetes.
- Preventing type 1 diabetes: UMass Chan researcher developing skin treatment, with potential broader applications to prevent diabeteson April 15, 2024 at 4:44 am
Dr. John Harris, professor and chair of the Department of Dermatology at UMass Chan Medical School in Worcester and founding director of the school’s Vitiligo Clinic and Research Center, Harris has ...
- Type 1 Diabetes: what are the signs and how to treat iton April 9, 2024 at 1:01 am
Type 1 diabetes appears to be on the rise – although we are not quite sure why. Before the pandemic, the rate of Type 1 in children was already increasing globally by around 3 per cent each year. In ...
- Landmark diabetes treatment could be offered in NIon April 3, 2024 at 8:04 am
Thousands of people with type 1 diabetes in Northern Ireland could be offered new technology, dubbed an artificial pancreas, to help manage the condition. The system uses a glucose sensor under the ...
- The U.K. is giving patients a treatment for the type of diabetes Ozempic can't treaton April 2, 2024 at 4:01 pm
The National Health Service in England will give out thousands of artificial pancreas systems to patients living with Type 1 diabetes, the government agency announced today.
- DELAY DIABETES: OU Health offers new treatment that could delay type 1 diabeteson March 26, 2024 at 9:15 am
While the treatment won’t work for 13-year-old Bay, who has stage 3 of type 1 diabetes, it could make a big difference for those with the early markers of the disease. The American Diabetes ...
- Cure for type-1 diabetes closer to reality through advances in genetic engineeringon March 22, 2024 at 10:07 am
Studies with monkeys show that injecting high-insulin-producing forms of these cells into the animals can “cure” type-1 diabetes for about six months. Human trials are underway. But a better solution ...
- Cure for type-1 diabetes closer to reality through advances in genetic engineeringon March 21, 2024 at 5:00 pm
Studies with monkeys show that injecting high-insulin-producing forms of these cells into the animals can “cure” type-1 diabetes for about six months. Human trials are underway. But a better ...
The Latest Google Headlines on:
Cure for type 1 diabetes
[google_news title=”” keyword=”cure for type 1 diabetes” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]